言語:
日文
English
簡体中文
繁體中文
ヘルプ
ログイン
ホームページ
検索結果
[ subject:"Cancer Research." ]
スイッチ:
ラベル
|
MARC形式
|
国際標準書誌記述(ISBD)
Lung cancer and personalized medicin...
~
Ahmad, Aamir.
Lung cancer and personalized medicine[electronic resource] :novel therapies and clinical management /
レコード種別:
言語・文字資料 (印刷物) : 単行資料
[NT 15000414] null:
616.9942406
タイトル / 著者:
Lung cancer and personalized medicine : novel therapies and clinical management // edited by Aamir Ahmad, Shirish M. Gadgeel.
その他の著者:
Ahmad, Aamir.
出版された:
Cham : : Springer International Publishing :, 2016.
記述:
x, 231 p. : : ill., digital ;; 24 cm.
含まれています:
Springer eBooks
主題:
Lungs - Cancer
主題:
Biomedicine.
主題:
Cancer Research.
国際標準図書番号 (ISBN) :
9783319249322
国際標準図書番号 (ISBN) :
9783319249315
[NT 15000229] null:
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
電子資源:
http://dx.doi.org/10.1007/978-3-319-24932-2
Lung cancer and personalized medicine[electronic resource] :novel therapies and clinical management /
Lung cancer and personalized medicine
novel therapies and clinical management /[electronic resource] :edited by Aamir Ahmad, Shirish M. Gadgeel. - Cham :Springer International Publishing :2016. - x, 231 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.8900065-2598 ;. - Advances in experimental medicine and biology ;946..
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
ISBN: 9783319249322
Standard No.: 10.1007/978-3-319-24932-2doiSubjects--Topical Terms:
447997
Lungs
--Cancer
LC Class. No.: RC280.L8
Dewey Class. No.: 616.9942406
Lung cancer and personalized medicine[electronic resource] :novel therapies and clinical management /
LDR
:01888nam a2200313 a 4500
001
455475
003
DE-He213
005
20160803145043.0
006
m d
007
cr nn 008maaau
008
161227s2016 gw s 0 eng d
020
$a
9783319249322
$q
(electronic bk.)
020
$a
9783319249315
$q
(paper)
024
7
$a
10.1007/978-3-319-24932-2
$2
doi
035
$a
978-3-319-24932-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC280.L8
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.9942406
$2
23
090
$a
RC280.L8
$b
L963 2016
245
0 0
$a
Lung cancer and personalized medicine
$h
[electronic resource] :
$b
novel therapies and clinical management /
$c
edited by Aamir Ahmad, Shirish M. Gadgeel.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
x, 231 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Advances in experimental medicine and biology,
$x
0065-2598 ;
$v
v.890
520
$a
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
650
0
$a
Lungs
$x
Cancer
$x
Treatment.
$3
447997
650
1 4
$a
Biomedicine.
$3
463454
650
2 4
$a
Cancer Research.
$3
463530
700
1
$a
Ahmad, Aamir.
$3
652251
700
1
$a
Gadgeel, Shirish M.
$3
653888
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
830
0
$a
Advances in experimental medicine and biology ;
$v
946.
$3
463635
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-24932-2
950
$a
Biomedical and Life Sciences (Springer-11642)
~に基づいて 0 論評
マルチメディア (複合媒体資料)
マルチメディアファイル
http://dx.doi.org/10.1007/978-3-319-24932-2
論評
論評を追加
あなたの考えを共有してください。
Export
受取館
処理
...
パスワードを変更する
ログイン